CARLSON CAPITAL L P - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
CARLSON CAPITAL L P ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$12,222,000
-52.1%
500,096
-49.2%
0.22%
-45.1%
Q4 2018$25,514,000
+46.5%
983,560
+78.7%
0.40%
+82.9%
Q3 2018$17,415,000
+99.2%
550,250
+144.6%
0.22%
+77.0%
Q2 2018$8,741,000
-8.4%
225,000
-34.9%
0.12%
-15.3%
Q1 2018$9,542,000
-64.9%
345,730
-77.0%
0.14%
-68.9%
Q4 2017$27,178,000
-14.7%
1,501,544
-23.9%
0.46%
-15.2%
Q3 2017$31,863,000
+9.8%
1,972,935
-5.8%
0.55%
+31.9%
Q2 2017$29,013,000
-12.1%
2,094,795
-4.8%
0.41%
-1.4%
Q1 2017$33,017,0002,201,1600.42%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders